10 studies found for:    Lupus AND Los Angeles | Open Studies
Show Display Options
Download search resultsDownload the search results for:
Lupus AND Los Angeles | Open Studies (10 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Epratuzumab;   Drug: Placebo
2 Recruiting Vitamin D3 in Pediatric SLE
Condition: Systemic Lupus Erythematosus
Intervention: Drug: Vitamin D3
3 Recruiting Functional MRI in Lupus Nephritis
Condition: Lupus Nephritis
Intervention:
4 Recruiting A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid;   Healthy
Interventions: Procedure: Skin biopsy;   Procedure: Blood collection;   Procedure: Urine collection
5 Recruiting Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
6 Recruiting Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
7 Recruiting Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Placebo;   Drug: Epratuzumab
8 Recruiting Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Mycophenolate Mofetil;   Drug: Hydroxychloroquine or Chloroquine;   Drug: Prednisone
9 Recruiting Anti-Tweak in Lupus Nephritis Patients
Condition: Lupus Nephritis
Interventions: Biological: BIIB023;   Biological: Placebo
10 Recruiting A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Tabalumab Auto-Injector;   Drug: Tabalumab Prefilled Syringe

Indicates status has not been verified in more than two years